Albuterol is better than epinephrine for treating bronchiolitis

I. Toller, M. Canciani

Source: Breathe 2008; 5: 74
Journal Issue: October

PDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
I. Toller, M. Canciani. Albuterol is better than epinephrine for treating bronchiolitis. Breathe 2008; 5: 74

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Comparison of treatments with nebulised salbutamol and epinephrine in acute bronchiolitis
Source: Eur Respir J 2004; 24: Suppl. 48, 344s
Year: 2004

Do infants with bronchiolitis get any benefit with nebulized salbutamol?
Source: Annual Congress 2011 - Biological correlates and comorbidities of childhood asthma/allergy
Year: 2011


Efficacy of nebulised adrenaline and salbutamol on mild to moderate bronchiolitis
Source: Annual Congress 2003 - New perspectives in bronchiolitis
Year: 2003


Τhe administration of nebulised racemic epinephrine in asthma exacerbations
Source: Eur Respir J 2004; 24: Suppl. 48, 541s
Year: 2004

Treating bronchiolitis: should we choose between epinephrine and beta-agonists?
Source: Eur Respir J 2001; 18: Suppl. 33, 169s
Year: 2001

IV salbutamol as alternative treatment to intubation in RSV epidemic acute infantile bronchiolitis
Source: Annual Congress 2003 - New perspectives in bronchiolitis
Year: 2003


Inefficiency of montelukast in acute bronchiolitis
Source: Breathe 2008; 5: 272-273
Year: 2009

Comparison of bronchodilators in acute bronchiolitis
Source: Eur Respir J 2002; 20: Suppl. 38, 16s
Year: 2002

Formoterol and budesonide/formoterol are both equally as fast and effective as salbutamol in relieving severe acute bronchospasm
Source: Eur Respir J 2004; 24: Suppl. 48, 541s
Year: 2004

Comparison of nebulized ipratropium bromide with salbutamol versus salbutamol alone in acute asthma exacerbation in children
Source: Eur Respir J 2004; 24: Suppl. 48, 167s
Year: 2004

Utility of inhaled corticosteroids (fluticasone/formoterol) by pressurized metered-dose inhaler for the early management of acute exacerbations of asthma
Source: Annual Congress 2010 - Aspects of severe asthma
Year: 2010

The role of nebulised budesonide in the treatment of acute exacerbations of COPD
Source: Eur Respir J 2007; 30: 399-400
Year: 2007


A randomized trial of the effectiveness of nebulized therapy with epinephrine compared with salbutamol in the treatment of acute viral bronchiolitis
Source: Eur Respir J 2005; 26: Suppl. 49, 127s
Year: 2005

Formoterol turbuhaler as a rescue therapy was as effective and safe as salbutamol by pMDI and spacer in patients with acute severe asthma
Source: Eur Respir J 2002; 20: Suppl. 38, 52s
Year: 2002

Administration of nebulized L-epinephrine in children with croup
Source: Eur Respir J 2006; 28: Suppl. 50, 266s
Year: 2006

RPL554, an inhaled PDE3/4 inhibitor, causes comparable bronchodilation to high dose nebulised salbutamol in asthmatics with fewer systemic effects
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016

Budesonide and formoterol in a single inhaler controls exacerbations more effectively than a higher dose of inhaled corticosteroids alone, in mild-moderate persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 43s
Year: 2001

Budesonide and formoterol in a single inhaler is more effective than a higher dose of inhaled corticosteroid in mild-moderate persistent asthma
Source: Eur Respir J 2001; 18: Suppl. 33, 159s
Year: 2001

Comparative effectiveness of steroids and bronchodilators for the acute care of bronchiolitis
Source: Annual Congress 2010 - From viral bronchiolitis to recurrent pneumonia in childhood: diagnosis, treatment and underlying factors
Year: 2010


The use of intravenous aminophylline in treatment of exacerbations of COPD
Source: Annual Congress 2004 - Acute exacerbations and drug therapy in COPD
Year: 2004